According to Horizon Therapeutics 's latest financial reports the company's current earnings (TTM) are $0.51 B. In 2022 the company made an earning of $0.61 B an increase over its 2021 earnings that were of $0.54 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $0.51 B | -16.06% |
2022 | $0.61 B | 12.27% |
2021 | $0.54 B | 17.91% |
2020 | $0.46 B | 589.84% |
2019 | $66.86 M | 42489.17% |
2018 | $0.15 M | -100.04% |
2017 | -$0.39 B | 173.37% |
2016 | -$0.15 B | 125.24% |
2015 | -$62.82 M | -74.45% |
2014 | -$0.25 B | 121.6% |
2013 | -$0.12 B | 42.93% |
2012 | -$77.63 M | 53.74% |
2011 | -$50.49 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Pfizer PFE | $3.26 B | 537.41% | ๐บ๐ธ USA |
Amgen AMGN | $7.85 B | 1,432.55% | ๐บ๐ธ USA |
Merck MRK | $3.03 B | 492.14% | ๐บ๐ธ USA |
AstraZeneca AZN | $8.49 B | 1,557.42% | ๐ฌ๐ง UK |
Dr. Reddy's RDY | $0.85 B | 66.61% | ๐ฎ๐ณ India |